Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
1.461
0.00 (0.03%)
May 14, 2025, 9:34 AM - Market open

Haoxi Health Technology Balance Sheet

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
9.16.661.20.290.06
Short-Term Investments
---0.120.12
Cash & Short-Term Investments
9.16.661.20.410.18
Cash Growth
428.12%453.17%193.39%126.85%-
Accounts Receivable
0.730.230.0100.67
Other Receivables
0.220.240.06--
Receivables
5.053.550.0701.97
Inventory
5.675.172.40.030.47
Other Current Assets
----0
Total Current Assets
19.8215.383.670.452.63
Property, Plant & Equipment
0.240.130.230.10.19
Long-Term Deferred Charges
--0.56--
Total Assets
22.0715.514.460.542.81
Accounts Payable
0.670.650.031.272.92
Accrued Expenses
-0.240.510.160.030.11
Short-Term Debt
0.820.830.510.440.18
Current Portion of Long-Term Debt
0.32-0.03--
Current Portion of Leases
0.08-0.090.070.09
Current Income Taxes Payable
0.90.680.250.040.02
Other Current Liabilities
0.731.191.510.171.35
Total Current Liabilities
3.293.872.582.014.68
Long-Term Debt
0.030.370.32--
Long-Term Leases
----0.07
Total Liabilities
3.324.232.92.014.74
Common Stock
0.010000
Additional Paid-In Capital
18.3410.592.180.180.03
Retained Earnings
0.490.72-0.57-1.54-1.78
Comprehensive Income & Other
-0.09-0.04-0.04-0.11-0.18
Shareholders' Equity
18.7411.271.57-1.47-1.93
Total Liabilities & Equity
22.0715.514.460.542.81
Total Debt
1.251.20.950.510.34
Net Cash (Debt)
7.845.450.25-0.1-0.15
Net Cash Growth
1176.18%2049.89%---
Net Cash Per Share
5.094.460.23-0.10-0.15
Filing Date Shares Outstanding
2.91.291.1811
Total Common Shares Outstanding
2.91.291.1811
Working Capital
16.5311.511.1-1.56-2.05
Book Value Per Share
6.478.741.33-1.47-1.93
Tangible Book Value
16.7311.271.57-1.47-1.93
Tangible Book Value Per Share
5.788.741.33-1.47-1.93
Machinery
0.160.160.150.010
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q